Cingulate Inc. Warrants

YTD

ALL

Why Robinhood?

You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!

About CINGW

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

CEO

Shane J. Schaffer, PharmD

CEOShane J. Schaffer, PharmD

Employees

—

Employees—

Headquarters

Kansas City, Kansas

HeadquartersKansas City, Kansas

Founded

2013

Founded2013

Employees

—

Employees—

CINGW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

7.67K

Average volume7.67K

High today

$0.0399

High today$0.0399

Low today

$0.0333

Low today$0.0333

Open price

$0.0333

Open price$0.0333

Volume

2.00K

Volume2.00K

52 Week high

$0.18

52 Week high$0.18

52 Week low

$0.0072

52 Week low$0.0072